ACRO BIOMEDICAL CO., LTD. Increase (Decrease) in Due to Related Parties
ACRO BIOMEDICAL CO., LTD. (ACBM) reported Increase (Decrease) in Due to Related Parties of $3.08 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-07-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2023-07-21
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in due to related parties for the quarter ending 2021-12-31 was $1.09K.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in due to related parties for the quarter ending 2021-09-30 was $3.72K.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in due to related parties for the quarter ending 2020-12-31 was $0.00.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in due to related parties for the quarter ending 2020-09-30 was $0.00.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in due to related parties for fiscal 2022 was $3.08K, a 84.29% decline from fiscal 2021.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in due to related parties for fiscal 2021 was $19.64K, a 91.88% decline from fiscal 2020.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in due to related parties for fiscal 2020 was $241.85K.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 6 month | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 12 month |
|---|---|---|---|---|
| 2022-12-31 | $3.08K 10-K · filed 2023-07-21 | |||
| 2021-12-31 | $1.09K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-21 | $4.81K derived: sum of 2 quarters · filed 2023-07-21 | $19.64K 10-K · filed 2023-07-21 | |
| 2021-09-30 | $3.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | $18.55K 10-Q · filed 2021-11-22 | ||
| 2021-06-30 | $14.83K 10-Q · filed 2021-08-23 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $0.00 derived: sum of 2 quarters · filed 2022-04-15 | $241.85K 10-K · filed 2022-04-15 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | $241.85K 10-Q · filed 2021-11-22 | ||
| 2020-06-30 | $241.85K 10-Q · filed 2021-08-23 | |||
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-03 | $6.00 10-Q · filed 2016-08-03 | ||
| 2015-03-31 | $6.00 10-Q · filed 2016-05-13 |